The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 27, 2003

Filed:

May. 07, 2002
Applicant:
Inventors:

Michael W. Leach, Shrewsbury, MA (US);

Mark R. Berardi, Sussex, NJ (US);

Elmer J. Mirro, Wantage, NJ (US);

Dineshwar Sinha, Newton, NJ (US);

Jonathan A. Pachter, Maplewood, NJ (US);

Mark E. Cartwright, Sparta, NJ (US);

Gregory A. Reichard, Morris Plains, NJ (US);

Assignee:

Schering Corporation, Kenilworth, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 3/1445 ; A61K 3/150 ;
U.S. Cl.
CPC ...
A61K 3/1445 ; A61K 3/150 ;
Abstract

Use of an antagonist selected from the group consisting of: (a) antagonists of neurokinin-1 (NK ), neurokinin-2 (NK ) and neurokinin-3 (NK ) receptors, (b) antagonists of NK and NK receptors, (c) antagonists of NK and NK receptors, (d) antagonists of NK and NK receptors, (e) antagonists of NK receptors, and (f) antagonists of NK to treat symptoms and disorders associated with a production and/or secretion of androgen. One aspect of the invention relates to the use of antagonists to suppress production/secretion of androgens in mammals suffering from an androgen-dependent disease, such as benign prostatic hyperplasia and prostatic carcinoma.


Find Patent Forward Citations

Loading…